Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System

NCT04433065 is registered in ClinicalTrials.gov with Medtronic Cardiovascular as lead sponsor.

NCT NCT04433065
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT04433065 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
The Early Feasibility Study of the Transcatheter Tricuspid Valve Replacement System Transfemoral System
Lead sponsor
Medtronic Cardiovascular
Phase
Not applicable
Overall status
Active, not recruiting
Start date
October 20, 2020
Completion date
August 26, 2031
Enrollment
150 (estimated)
Sites
20

Conditions

As the registry lists them; a condition with its own page is linked.

tricuspid regurgitation